This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

DONALD M. HAYES, MD; F. B. WILKINS, MD; JESSE H. MEREDITH, MD

AMA Arch Surg. 1964;88(6):1070-1076.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Malignant tumors of the head and neck region are regarded lightly by many clinicians and have not received the attention given in recent years to malignancies of other portions of the body. Survival rates for patients with such tumors belie this impression and show that these lesions are equally as deadly as other tumors. The five-year survival rate for carcinoma of the tongue has been given as 38.5%, for the buccal mucosa 47.1%, and for the gingiva as 42.2% in one series.¹ These tumors are also regarded as less deadly than others because they do not commonly metastasize. However, the study of Rubenfeld et al showed that 28 (21%) of 132 patients with carcinomas of the head and neck region had distant metastases.¹⁰ It is obvious from these data that this is indeed a formidable group of tumors and one for which the standard treatment leaves much to . . . [Full Text PDF of this Article]

Author Affiliations
WINSTON-SALEM, NC

Department of Medicine (Dr. Hayes) Pathology (Dr. Wilkins), and Surgery (Dr. Meredith), The Bowman Gray School of Medicine of Wake Forest College.

Footnotes
Read before the 54th Annual Meeting of the American Association for Cancer Research, Toronto, Canada, May, 1963.

Supported in part by United States Public Health Service grant CA-03927-06 and by a grant from the Charlotte Community Fund, Charlotte, NC.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?